Alessandro Santin

35PUBLICATIONS
120CO-AUTHORS
Reproductive medicine not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jun 18, 2026
Reply to Hojný et al.: Fusion-driven vs. fusion-negative high-grade endometrial stromal sarcoma.

|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Jan 27, 2026
Integrated mutational landscape analysis of endometrial stromal sarcoma.

Tobias M P Hartwich, Seungji Choi, Ayoung Hwang

|Sep 27, 2025
Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor.

Cem Demirkiran, Stefania Bellone, Victoria M Ettorre

|Aug 27, 2025
HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma.

Victoria M Ettorre, Luca Palmieri, Valentino Clemente

|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.

Niccolò G Santin, Namrata Sethi, Stefania Bellone

Pageof 6

Frequent Collaborators

11 joint publications

Gloria Shining Huang

10 joint publications

Blair McNamara

9 joint publications

Natalia Buza

7 joint publications

Stefania Bellone